- Home
- BCRX vs ADUS Comparison
BCRX vs ADUS Comparison
Compare BCRX & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | ADUS |
|---|---|---|
| Founded | 1986 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1995 | 2009 |
Fundamental Metrics
Financial Performance| Metric | BCRX | ADUS |
|---|---|---|
| Price | $8.47 | $111.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $20.82 | ★ $133.78 |
| AVG Volume (30 Days) | ★ 4.2M | 150.6K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | 23.40 |
| EPS | N/A | ★ 2.85 |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | $9.17 |
| Revenue Next Year | $12.55 | $4.70 |
| P/E Ratio | ★ N/A | $39.76 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $87.95 |
| 52 Week High | $11.22 | $124.44 |
Technical Indicators
Market Signals| Indicator | BCRX | ADUS |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | 38.96 |
| Support Level | $8.04 | $106.38 |
| Resistance Level | $10.05 | $121.38 |
| Average True Range (ATR) | 0.32 | 2.86 |
| MACD | -0.00 | -0.65 |
| Stochastic Oscillator | 35.56 | 10.10 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.